US 8492337
Targeted therapeutic proteins
granted A61KA61K2039/505A61K2039/515
Quick answer
US patent 8492337 (Targeted therapeutic proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/505, A61K2039/515, A61K35/12, A61K35/54